619 135pg Peg-IFN alpha-2a in combination with weight based ribavirin for genotype 2 and 3 is highly efficaciousdoi:10.1016/S0168-8278(06)80619-7O.WeilandandR.SchvarczandL.MattssonandH.SDOSJournal of Hepatology
280 RETREATMENT WITH PEG-IFN ALPHA-2A PLUS RIBAVIRIN FOR 48 WEEKS IN CHRONIC HEPATITIS C GENOTYPE 2 AND 3 RELAPSERS TO A PREVIOUS ANTIVIRAL TREATMENTdoi:10.1016/S0168-8278(10)60282-6E.MinolaandV.BaldoandT.BaldovinandA.SDOSJournal of Hepatology...
Claim 1: The positional isomers of pegylated interferon alpha 2S selected from the group PEG-Lys (31), PEG-Lys (49), PEG-Lys (83), PEG-Lys (112), PEG-Lys (121), PEG -Lys (131), PEG-Lys (134) and PEG-Lys (164).BRUGGER, DORIS...
P.233 RETREATMENT WITH PEG-IFN ALPHA-2A PLUS RIBAVIRIN FOR 48 WEEKS IN CHRONIC HEPATITIS C GENOTYPE 2 AND 3 RELAPSERS TO A PREVIOUS ANTIVIRAL TREATMENTdoi:10.1016/s1590-8658(10)60345-3E. MinolaV. BaldoT. BaldovinA. FloreaniElsevier BVDigestive & Liver Disease...
280 RETREATMENT WITH PEG-IFN ALPHA-2A PLUS RIBAVIRIN FOR 48 WEEKS IN CHRONIC HEPATITIS C GENOTYPE 2 AND 3 RELAPSERS TO A PREVIOUS ANTIVIRAL TREATMENTdoi:10.1016/s0168-8278(10)60282-6E. MinolaV. BaldoT. BaldovinA. Floreani
Joy, JaimyMarino, FrancescoKrause, RyanPetropoulos, Christos J.Papasavvas, EmmanouilFair, MatthewMounzer, KaramTebas, PabloMontaner, Luis J.Bar, KatharineTopics in Antiviral Medicine
P.233 RETREATMENT WITH PEG-IFN ALPHA-2A PLUS RIBAVIRIN FOR 48 WEEKS IN CHRONIC HEPATITIS C GENOTYPE 2 AND 3 RELAPSERS TO A PREVIOUS ANTIVIRAL TREATMENTdoi:10.1016/S1590-8658(10)60345-3E.MinolaandV.BaldoandT.BaldovinandA.SDOSDigestive & Liver Disease...